macrogenics.com
域名年龄: 24年11个月28天HTTP/1.1 200 OK 访问时间:2014年12月03日 12:29:27 缓存控制:no-store, 不缓存,必须更新, post-check=0, pre-check=0 其他指令:不缓存 设置Cookie:PHPSESSID=9hlf2gj0cmm3gr6ispoobka800; path=/ Keep-Alive: timeout=15, max=100 连接:Keep-Alive Transfer-Encoding: chunked 类型:text/html 页面编码:utf-8
MacroGenics HomepageAbout UsApproachCapabilitiesSenior ManagementBoard of DirectorsPipelineMargetuximab (HER2)MGA271 (B7-H3)MGD006 (CD123 x CD3)MGD007 (gpA33 x CD3)MGD010 (CD32B x CD79B)Teplizumab (CD3)PlatformsDART™Cancer Stem CellsFc OptimizationPartneringCollaboratorsInvestor RelationsPress ReleasesEvents & PresentationsCorporate GovernanceSenior ManagementBoard of DirectorsCommitteesContact the BoardFinancial InformationSEC FilingsAnnual ReportsQuarterly ResultsKey RatiosStock InformationHistoric Stock LookupInvestment CalculatorDividend HistoryAnalyst CoverageOwnership ProfileInvestor FAQsPublicationsContact UsCareersEmployee Benefits11:29 PM | December 02, 2014Contact Us|Home|Search printGet the Flash Player to see this video.MacroGenics’ mission is to discover, develop and deliver to patients novel biologics for the treatment of cancer, autoimmune disorders and infectious diseases. Learn MoreMacroGenics' Corporate Fact Sheet Product Pipeline HighlightsView full chartProgram (Target)IndicationPre-Clin.Ph.1Ph.2 Ph.3 ONCOLOGY Margetuximab (HER2)Gastroesophageal * * * * Metastatic Breast * * * * Solid Tumors * * * * MGA271 (B7-H3)Solid Tumors * * * * MGD006 (CD123 x CD3)AML * * * * MGD007 (gpA33 x CD3)Colorectal * * * * AUTOIMMUNE Teplizumab (CD3)T1D - At-Risk * * * * MGD010 (CD32B x CD79B)Lupus, RA * * * * Overview Since its founding in 2000, MacroGenics has applied its world-class antibody capabilities to create life-changing medicines. The company’s innovative product candidates leverage its fully-integrated capabilities and its multiple, proprietary technology platforms. Learn more Company Highlights Robust pipeline in oncology and autoimmune disorders Partners include Takeda, Gilead, Servier, Pfizer and Boehringer Ingelheim Fully-integrated biologics capabilities across product development process Strong financial position Experienced leadership and highly collaborative corporate culture Learn more Partnering MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.Learn more Fierce Biotech 2013 MacroGenics was selected as a 2013 Fierce 15 by Fierce Biotech. Learn more ©2014 MacroGenics, Inc. About Us | Platforms | Pipeline | News & Media | Contact Us | Partnering | Sitemap | Home
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2025-06-24 16:37, Process in 0.0083 second.